Pancreatic Cancer Detection Consortium
City of Hope Medical Center · NCT06388967
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 2000
- US sites recruiting
- 9
- Study start
- March 15, 2023
- Record last updated
- September 28, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study aims to prospective validate an exosome-based miRNA signature for noninvasive and early detection of pancreatic ductal adenocarcinoma.
Being studied: PANcreatic cancer Exosome Early detectiON (PANXEON)
Conditions: Pancreatic Cancer; Pancreatic Carcinoma; Pancreatic Adenocarcinoma; Pancreatic Ductal Adenocarcinoma; Pancreatic Neoplasms; Pancreatic Cancer Stage I; Pancreatic Cancer Stage; Pancreatic Cancer Resectable; Pancreatic Cancer Stage 0; Pancreatic Cancer Stage II; Pancreatic Cancer Stage III; Pancreatic Cancer, Adult; Pancreatic Cancer Non-resectable
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Histological diagnosis of pancreatic ductal adenocarcinoma, stages I-IV (TNM classification, 8th edition)
- Received standard diagnostic and staging procedures as per local guidelines, and at least one sample was drawn before receiving any curative-intent treatment.
- Imaging- or endoscopy-based proof of lack of pancreatic ductal adenocarcinoma at the time of sampling (Non-disease controls)
Exclusion Criteria
- Lack of written informed consent.
Recruiting US locations
Translational Genomics Research Institute
Phoenix, AZ 85004
Site contact: Daniel Von Hoff · dvh@tgen.org
City of Hope Medical Center
Monrovia, CA 91016
Site contact: Ajay Goel, PhD · 626-218-3452 · AJGOEL@COH.ORG
OSF HealthCare
Peoria, IL 61637
Site contact: Chandler Wilfong · chandler.d.wilfong@osfhealthcare.org
Ochsner Medical Center
Jefferson, LA 70121
Site contact: John Bolton · jbolton@ochsner.org
Atlantic Health System
Morristown, NJ 07960
Site contact: Angela Alistar · angela.alistar@atlantichealth.org
AHN Cancer Institute at Allegheny General Hospital
Pittsburgh, PA 15212
Site contact: Ali Zaidi, MD · ali.zaidi@ahn.org
Piedmont Medical Center
Rock Hill, SC 29732
Site contact: Andrew Page · Andrew.Page@piedmont.org
MultiCare Cancer Institute - Tacoma General Hospital
Tacoma, WA 98405
Site contact: Alex Cantafio, MD · alex.cantafio@multicare.org
Medical College of Wisconsin
Milwaukee, WI 53226
Site contact: Douglas Evans · devans@mcw.edu
Study contacts (from the official record)
- Ajay Goel, PhD · 6262183452 · AJGOEL@COH.ORG
Similar studies in Arizona
All healthy volunteers studies in Arizona →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Developing Biomarkers of Dietary Intake: Dose Dependent Measurement of Sugar Intake
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Location
- Phoenix, AZ
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234
AstraZeneca
- Location
- Chandler, AZ + 2 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingHealthy volunteersPhase 1
A Phase 1 Relative Bioavailability Study of a VX-581 Tablet Formulation
Vertex Pharmaceuticals Incorporated
- Location
- Tempe, AZ
- Eligibility basics
- Ages 18–55 · Men only
- RecruitingHealthy volunteersPhase 1
A Single and Multiple Ascending Dose Study of EPX-100 in Healthy Adult Participants
Epygenix
- Location
- Tempe, AZ
- Eligibility basics
- Ages 18–55